CBIH (Cannabis Bioscience International Holdings) Short Interest

View and export this data going back to 2008. Start your Free Trial

What is Cannabis Bioscience International Holdings Short Interest?

Short Interest can be expressed as a percentage by dividing the number of shares sold short by the total number of outstanding shares.

Due to the license agreement change with our data vendor, Short Interest related data is no longer available on GuruFocus website.

Competitive Comparison of Cannabis Bioscience International Holdings's Short Interest

For the Drug Manufacturers - Specialty & Generic subindustry, Cannabis Bioscience International Holdings's Short Interest, along with its competitors' market caps and Short Interest data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Cannabis Bioscience International Holdings's Short Interest Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Cannabis Bioscience International Holdings's Short Interest distribution charts can be found below:

* The bar in red indicates where Cannabis Bioscience International Holdings's Short Interest falls into.

Cannabis Bioscience International Holdings Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Cannabis Bioscience International Holdings Inc (OTCPK:CBIH) » Definitions » Short Interest

Comparable Companies

Traded in Other Exchanges

N/A

Address

6201 Bonhomme Road, Suite 435N, Houston, TX, USA, 77036

Website

https://www.cbih.net

Cannabis Bioscience International Holdings Inc provides educational systems focused on medical cannabis in cities throughout the United States and six countries in Latin America. The company provides services in therapeutic areas of clinical trials and services relating to sleep disorders through its sleep center in Houston, Texas. It offered concierge medicine at an affordable price through a membership-based model through its wholly-owned subsidiary.